eHealth Q2 revenue slightly exceeds analyst expectations
eHealth Q2 revenue slightly exceeds analyst expectations
Overview
Online health insurance marketplace's Q2 revenue slightly beat analyst expectations
Outlook
Company did not provide specific guidance or outlook in the press release
Result Drivers
TECHNOLOGY AND CUSTOMER APPROACH - Co highlights use of data, artificial intelligence and consumer-first approach to help customers compare insurance options
Company press release: ID:nPn9C4l2Sa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Slight Beat* | $33.60 mln | $33.29 mln (5 Analysts) |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the multiline insurance & brokers peer group is "buy."
Wall Street's median 12-month price target for eHealth Inc is $2.50, about 81.2% above its August 3 closing price of $1.38
The stock recently traded at 1 times the next 12-month earnings vs. a P/E of 2 three months ago
Reuters Recommended Reads
Aug 3 - EverQuote Q2 revenue beats estimates on auto, home insurance demand
Aug 3 - Ethos Technologies Q2 revenue rises 113% on policy growth
Aug 3 - HealthStream Q2 revenue beats estimates, helped by acquisitions
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on eHealth
See all newseHealth Inc reports results for the quarter ended June 30 - Earnings Summary
eHealth Q2 revenue slightly exceeds analyst expectations
eHealth Inc expected to post a loss of 71 cents a share - Earnings Preview
Brief: eHealth, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Brief: Ehealth Announces $125 Million Asset-Based Revolving Credit Facility